Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 3NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 3

Conditions

Ovarian Neoplasms 2Refractory Malignant Ascites 1Ovarian High Grade Serous Adenocarcinoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Paracentesis × Clear all
NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University

Phase 2 Recruiting
28 enrolled
Gynecologic

Ovarian High Grade Serous Adenocarcinoma

NCT02477657 2022-01-12

Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology

Abramson Cancer Center at Penn Medicine

Withdrawn

Refractory Malignant Ascites

NCT04032600 2020-12-08

ATLANTIS

Charite University, Berlin, Germany

Phase NA Completed
61 enrolled
Gynecologic

Ovarian Neoplasms

NCT02441140 2020-05-04

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Dana-Farber Cancer Institute

Phase NA Terminated
5 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡